Skip to content

Exercise, Gut Microbiota in Sedentary Adults With Overweight

Effect of Two Exercise Programme on Gut Microbiota, Hepatic Metabolism and Adipokines in Sedentary Adults With Overweight

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03515642
Enrollment
0
Registered
2018-05-03
Start date
2018-03-25
Completion date
2019-08-30
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Disturbance

Keywords

Gut microbiota, Hepatic function, Obesity, Exercise

Brief summary

This project offers the opportunity to obtain detailed measurements on the health of body composition, metabolic health, and intestinal microbial diversity in overweight adults; moreover to provide information about the effects of physical exercise on them. The aim of the research is to advance in the understanding of the mechanisms induced by physical exercise, which includes the measurement of nutritional parameters, clinical and biochemical biomarkers of hepatic/cardiometabolic health, as well as the application of differential proteomics technologies by means of Arrays of cytokines and intestinal microbiome, making this study a novel and pioneer in sensitive areas of primary health care in Latin America.

Interventions

BEHAVIORALHIIT group

Physical Training

Sponsors

Universidad de Santiago de Chile
CollaboratorOTHER
Universidad Pública de Navarra
CollaboratorOTHER
Universidad del Rosario
CollaboratorOTHER
NavarraBiomed Biomedical Research Center
CollaboratorOTHER
Universidad Santo Tomas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Sedentary males * BMI\>25 kg/m2, on a stable body weight for the last 3 months

Exclusion criteria

* Acute or chronic illness * Use of antibiotics the past 2 months * Smoking

Design outcomes

Primary

MeasureTime frameDescription
Gut microbiotaBaseline, and 6 weeks immediately after the interventions endsChange from Baseline in the gut microbiota composition measured by amplicon sequencing
Plasma metabolomic profileBaseline, and 6 weeks immediately after the interventions endsChange from Baseline in the metabolomic profile will be also evaluated by a HPLC-MS approach

Secondary

MeasureTime frameDescription
InsulinBaseline, and 6 weeks immediately after the interventions endsChange from Baseline will be also evaluated by a ELISA
Body compositionBaseline, and 6 weeks immediately after the interventions endsDifferences in body weight (kilograms) measured by DXA
Glycated hemoglobinBaseline, and 6 weeks immediately after the interventions endsChange from Baseline will be also evaluated by a ELISA
Plasma hepatokinesBaseline, and 6 weeks immediately after the interventions endsChange from Baseline in the Chemerin will be measured using ELISA kits
Physical fitnessBaseline, and 6 weeks immediately after the interventions endsDifferences in Muscular strength (handgrip test) in kg
Energy substrate oxidationBaseline, and 6 weeks immediately after the interventions endsFat and carbohydrate oxidation in the fasted and postprandial state measured before and after the interventions using indirect calorimetry (K5 cosmed)
Resting Metabolic RateBaseline, and 6 weeks immediately after the interventions endsResting metabolic rate was measured before and after the interventions (K5 Cosmed)
Bioinflammatory blood markersBaseline, and 6 weeks immediately after the interventions endsChange from Baseline measure of plasma IL-1 concentrations measured ELISA
GlucoseBaseline, and 6 weeks immediately after the interventions endsChange from Baseline will be also evaluated by a spectroscopy

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026